These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 16854824)
1. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Fung AE; Rosenfeld PJ; Reichel E Br J Ophthalmol; 2006 Nov; 90(11):1344-9. PubMed ID: 16854824 [TBL] [Abstract][Full Text] [Related]
2. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Wong LJ; Desai RU; Jain A; Feliciano D; Moshfeghi DM; Sanislo SR; Blumenkranz MS Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542 [TBL] [Abstract][Full Text] [Related]
3. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G Retina; 2006; 26(5):495-511. PubMed ID: 16770255 [TBL] [Abstract][Full Text] [Related]